MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma

被引:0
|
作者
Pamposh Raina
S. K. Singh
Anil K. Goswami
Manoj Kumar Kashyap
Madhu Khullar
S. K. Sharma
Kailash Chander Barwal
机构
[1] Indira Gandhi Medical College,Department of Urology
[2] Postgraduate Institute of Medical Education & Research,Department of Urology
[3] Postgraduate Institute of Medical Education & Research,Department of Experimental Medicine and Biotechnology
[4] Amity University Haryana,Amity Stem Cell Institute, Amity Medical School
[5] Amity Education Valley,undefined
来源
关键词
RT-PCR; cDNA synthesis; Renal cell carcinoma; RCC; Blood; Urine;
D O I
暂无
中图分类号
学科分类号
摘要
MN/CA9 is a cell surface glycoprotein and a tumor-associated antigen. It plays a crucial role in the regulation of cell proliferation and oncogenesis. There is no ideal tumor marker currently available for renal cell carcinoma (RCC) with sufficient sensitivity and specificity. Therefore, we studied MN/CA9 gene expression in the tumor tissue, apparently normal kidney tissue, preoperative blood, and urine samples of patients with RCC. We included thirty cases of renal tumors (26 RCC and 4 benign tumors) in the study. We applied an RT-PCR assay for MN/CA9 gene expression to 26 RCC kidney tumor samples and four benign kidney tumor tissue samples. We also evaluated MN/CA9 gene expression in preoperative blood and urine samples of 15 of these cases. Additionally, thirty-five grossly normal renal tissue samples, including 21 from kidneys with RCC, were also evaluated for gene expression. The RT-PCR analysis revealed that twenty-one out of 26 RCC tissue samples showed MN/CA9 gene expression compared to three out of 35 non-malignant renal tissue samples (p < 0.05). Two out of four benign renal tissue samples also expressed this gene. We also observed MN/CA9 gene expression in nine out of 15 blood samples and four out of 15 urine samples. All patients with urinary MN/CA9 gene expression showed expression in blood and tumor tissue samples. We found a correlation in terms of MN/CA9 expression between blood and tumor tissue samples of RCC patients as those who exhibit MN/CA9 expression in blood were also positive at the tumor tissue levels. The difference in MN/CA9 gene expression in tumor tissue, blood, and urine samples in relation to the stage of the disease, nuclear grade, and histological cell-type was not statistically significant. However, all the three patients who had metastatic RCC had MN/CA9 gene expression in their blood. The existence of a tumor-associated antigen such as MN/CA9 may present a possible target for molecular diagnosis and management of RCC.
引用
收藏
页码:333 / 343
页数:10
相关论文
共 50 条
  • [21] Expression of carbonic anhydrase IX (CA9) in renal neoplasms: Implications for use as diagnostic marker
    Zhou, M.
    Magi-Galluzzi, C.
    MODERN PATHOLOGY, 2007, 20 : 186A - 186A
  • [22] Carbonic Anhydrase IX (CA9) Expression in Multiple Renal Epithelial Tumor Subtypes
    Baniak, Nicholas
    Hirsch, Michelle
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 860 - 860
  • [23] Carbonic Anhydrase IX (CA9) Expression in Multiple Renal Epithelial Tumor Subtypes
    Baniak, Nicholas
    Hirsch, Michelle
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 860 - 860
  • [24] Expression of carbonic anhydrase IX (CA9) in renal neoplasms: Implications for use as diagnostic marker
    Zhou, M.
    Magi-Galluzzi, C.
    LABORATORY INVESTIGATION, 2007, 87 : 186A - 186A
  • [25] CA9 GENE SINGLE NUCLEOTIDE POLYMORPHISMS PREDICT PROGNOSIS AND TREATMENT RESPONSE OF METASTATIC RENAL CELL CARCINOMA
    De Martino, M.
    Klatte, T.
    Seligson, D. B.
    Larochelle, J. C.
    Shuch, B.
    Caliliw, R. R.
    Li, Z.
    Kabbinavar, F. F.
    Pantuck, A. J.
    Belldegrun, A. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 297 - 297
  • [26] CA9 as a molecular marker for differential diagnosis of cystic renal tumors
    Li, Guorong
    Bilal, Issam
    Gentil-Perret, Anne
    Feng, Gang
    Zhao, An
    Peoc'h, Michel
    Genin, Christian
    Tostain, Jacques
    Gigante, Marc
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (04) : 463 - 468
  • [27] CA9 MRNA IS HIGHLY DETECTABLE IN THE SERUM OF PATIENTS WITH CLEAR CELL RENAL CELL CARCINOMA
    Li, G.
    Feng, G.
    Zhao, A.
    Gentil-Perret, A.
    Paul, S.
    Genin, C.
    Gigante, M.
    Tostain, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 118 - 118
  • [28] The functional role of CA9 and glucose transporters (GLUT) in human renal cell carcinoma
    Medina Villaamil, V.
    Aparicio Gallego, G.
    Santome Couto, L.
    Afonso Afonso, J.
    Fernandez Calvo, O.
    Anido Herranz, U.
    Leon Mateos, L.
    Ramos Vazquez, M.
    Lazaro Quintela, M. E.
    Firvida Perez, J. L.
    Santamarina Cainzos, I.
    Anton Aparicio, L. M.
    BJU INTERNATIONAL, 2012, 110 : 13 - 13
  • [29] Induction of specific anti-tumor responses by CA9 peptide vaccination in patients with metastatic renal cell carcinoma
    Uemura, Hirotsugu
    Uejima, Shigeya
    Tanaka, Motoyoshi
    Fujimoto, Kiyohide
    Hirao, Yoshihiko
    Itoh, Kyogo
    CANCER RESEARCH, 2006, 66 (08)
  • [30] Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney
    Liao, SY
    Aurelio, ON
    Jan, K
    Zavada, J
    Stanbridge, EJ
    CANCER RESEARCH, 1997, 57 (14) : 2827 - 2831